New hope for myasthenia gravis: experimental drug CNP-106 enters human trials

NCT ID NCT06106672

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests an experimental drug called CNP-106 in 54 adults aged 18-75 with generalized myasthenia gravis, a condition that causes muscle weakness. The goal is to check if the drug is safe and how it affects the immune system. Participants receive either CNP-106 or a placebo, and researchers monitor side effects and immune cell changes over 6 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENERALIZED MYASTHENIA GRAVIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myasthenia gravis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Atlantis Research

    Miami, Florida, 33173, United States

  • Barrow Neurological Institute

    Phoenix, Arizona, 85013, United States

  • Infusion for Health

    Brea, California, 92835, United States

  • Insight Hospital and Medical Center

    Chicago, Illinois, 60608, United States

  • Insight Research Institute, Dearborn

    Dearborn, Michigan, 48126, United States

  • Medical University of South Carolina

    Charleston, South Carolina, 29425, United States

  • Nerve and Muscle Center of Texas

    Houston, Texas, 77030, United States

  • Ohio State University Wexner Medical Center

    Colombus, Ohio, 43221, United States

  • Prolato Clinical Research Center

    Houston, Texas, 77054, United States

  • Quantix Research, LLC

    Miami, Florida, 33173, United States

  • University of California, Davis

    Sacramento, California, 95817, United States

  • University of California, Irvine

    Orange, California, 92868, United States

  • University of Kansas Medical Center

    Kansas City, Kansas, 66160, United States

  • University of Missouri, NextGen Precision Health

    Columbia, Missouri, 65211, United States

  • University of South Florida

    Tampa, Florida, 33612, United States

  • Virginia Commonwealth University

    Richmond, Virginia, 23298, United States

  • Yale University

    New Haven, Connecticut, 06516, United States